PEAK PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/faf0824b-e097-43ac-8abe-905bc9c2078b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-163.3k | 2021-10-01 – 2022-09-30 | evidence 0001199835-22-000838 |
| FY 2021 | $-68.7k | 2020-10-01 – 2021-09-30 | evidence 0001199835-22-000830 |
| FY 2020 | $-5.5k | 2019-10-01 – 2020-09-30 | evidence 0001199835-22-000822 |
| FY 2019 | $-5.7k | 2018-10-01 – 2019-09-30 | evidence 0001199835-22-000814 |
| FY 2018 | $-27.8k | 2017-10-01 – 2018-09-30 | evidence 0001199835-22-000806 |
| FY 2017 | $-45.0k | 2016-10-01 – 2017-09-30 | evidence 0001199835-18-000004 |
| FY 2016 | $1.1M | 2015-09-30 – 2016-09-30 | evidence 0001199835-18-000004 |
| FY 2015 | $-2.3M | 2014-10-01 – 2015-09-30 | evidence 0001654954-17-008392 |
| FY 2013 | $-956.9k | 2007-12-18 – 2014-03-31 | evidence 0001477932-14-002499 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).